Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.71
+0.18 (3.25%)
Last updated: Mar 10, 2026, 3:05 PM HKT
18.22%
Market Cap 1.35B
Revenue (ttm) 93.32M
Net Income (ttm) -83.29M
Shares Out 244.71M
EPS (ttm) -0.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 49,200
Average Volume 48,320
Open 5.61
Previous Close 5.53
Day's Range 5.61 - 5.77
52-Week Range 3.20 - 14.02
Beta -1.18
RSI 46.57
Earnings Date Mar 27, 2026

About HKG:6922

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People’s Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2013
Employees 180
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6922
Full Company Profile

Financial Performance

In 2024, HKG:6922's revenue was 53.53 million, an increase of 30.72% compared to the previous year's 40.95 million. Losses were -104.37 million, 7.06% more than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.